| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sahand Ashrafpour, Mohammad-Javad Nasr-Taherabadi, Alie Sabouri-Rad, Soheila Hosseinzadeh, Fereshteh Pourabdolhossei. Arbutin Intervention Ameliorates Memory Impairment in a Rat Model of lysolecethin induced Demyelination: Neuroprotective and Anti-Inflammatory Effects. Behavioural brain research. 2024-05-09. PMID:38723674. |
cognitive impairment (ci) and memory deficit are prevalent manifestations of multiple sclerosis (ms). |
2024-05-09 |
2024-05-27 |
rat |
| Robert Zivadinov, Niels Bergsland, Dejan Jakimovski, Bianca Weinstock-Guttman, Lorena Lorefice, Menno M Schoonheim, Sarah A Morrow, Mary Ann Picone, Gabriel Pardo, Myassar Zarif, Mark Gudesblatt, Jacqueline A Nicholas, Andrew Smith, Samuel Hunter, Stephen Newman, Mahmoud A AbdelRazek, Ina Hoti, Jon Riolo, Diego Silva, Tom A Fuchs, Michael G Dwyer, Ralph Hb Benedic. Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis. NeuroImage. Clinical. vol 42. 2024-05-08. PMID:38718640. |
prior research has established a link between thalamic pathology and cognitive impairment (ci) in people with multiple sclerosis (pwms). |
2024-05-08 |
2024-05-27 |
Not clear |
| Lorenzo Gaetani, Nicola Salvadori, Giovanni Brachelente, Silvia Sperandei, Elena Di Sabatino, Andrea Fiacca, Andrea Mancini, Alfredo Villa, Nicola De Stefano, Lucilla Parnetti, Massimiliano Di Filipp. Intrathecal B cell activation and memory impairment in multiple sclerosis. Multiple sclerosis and related disorders. vol 85. 2024-03-21. PMID:38513467. |
cognitive impairment (ci) is a common and disabling feature of people with multiple sclerosis (pwms), but its underlying mechanisms are heterogenous and not fully understood. |
2024-03-21 |
2024-03-24 |
Not clear |
| Aliz Nyári, Zsófia Kokas, Szabolcs Szamosi, Zsanett Fricska-Nagy, Judit Füvesi, Zsigmond Tamás Kincses, Tamás Biernacki, László Vécsei, Péter Klivényi, Krisztina Bencsik, Dániel Sand. The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2024-01-27. PMID:38280085. |
cognitive impairment (ci) is a frequent symptom of multiple sclerosis (ms) and has a great impact on the patients' quality of life, so screening is essential. |
2024-01-27 |
2024-01-30 |
Not clear |
| Emma Bränn, Yufeng Chen, Huan Song, Krisztina D László, Brian M D'Onofrio, Elgeta Hysaj, Catarina Almqvist, Henrik Larsson, Paul Lichtenstein, Unnur A Valdimarsdottir, Donghao L. Bidirectional association between autoimmune disease and perinatal depression: a nationwide study with sibling comparison. Molecular psychiatry. 2024-01-09. PMID:38191927. |
the bidirectional association was more pronounced among women without psychiatric comorbidities (nested case-control or: 1.5, 95% ci 1.4-1.6, matched cohort hr: 1.4, 95% ci 1.4-1.5) and strongest for multiple sclerosis (nested case-control or: 2.0, 95% ci 1.6-2.3, matched cohort hr: 1.8, 95% ci 1.0-3.1). |
2024-01-09 |
2024-01-10 |
Not clear |
| Adriana Aguayo-Arelis, Brenda Viridiana Rabago-Barajas, Ana Miriam Saldaña-Cruz, Miguel Ángel Macías-Isla. Association of the Genes. vol 14. issue 12. 2023-12-23. PMID:38136952. |
multiple sclerosis (ms) is a chronic inflammatory disease that affects the cerebral white matter of the brain cortex and spinal cord, leading to cognitive impairment (ci) in 40-60% of the patients. |
2023-12-23 |
2023-12-25 |
Not clear |
| Zichun Yan, Shiqi Yuan, Qiyuan Zhu, Xiaohua Wang, Zhuowei Shi, Yu Zhang, Jie Liu, Jinzhou Feng, Yiqiu Wei, Feiyue Yin, Shanxiong Chen, Yongmei L. Radiomics models based on cortical damages for identification of multiple sclerosis with cognitive impairment. Multiple sclerosis and related disorders. vol 81. 2023-12-07. PMID:38061318. |
cognitive impairment (ci) is a common symptom in multiple sclerosis (ms) patients. |
2023-12-07 |
2023-12-17 |
Not clear |
| Shun Akaike, Tomoko Okamoto, Ryoji Kurosawa, Nozomi Onodera, Youwei Lin, Wakiro Sato, Takashi Yamamura, Yuji Takahash. Exploring the Potential of the Corpus Callosum Area as a Predictive Marker for Impaired Information Processing in Multiple Sclerosis. Journal of clinical medicine. vol 12. issue 21. 2023-11-14. PMID:37959412. |
early cognitive impairment (ci) detection is crucial in multiple sclerosis (ms). |
2023-11-14 |
2023-11-20 |
Not clear |
| Sean L Carter, Ronak Patel, John D Fisk, Chase R Figley, Ruth Ann Marrie, Erin L Mazerolle, Md Nasir Uddin, Kaihim Wong, Lesley A Graff, James M Bolton, James J Marriott, Charles N Bernstein, Jennifer Kornelse. Differences in resting state functional connectivity relative to multiple sclerosis and impaired information processing speed. Frontiers in neurology. vol 14. 2023-11-06. PMID:37928146. |
fifty-one percent of individuals with multiple sclerosis (ms) develop cognitive impairment (ci) in information processing speed (ips). |
2023-11-06 |
2023-11-08 |
Not clear |
| Viktor Grut, Martin Biström, Jonatan Salzer, Pernilla Stridh, Daniel Jons, Rasmus Gustafsson, Anna Fogdell-Hahn, Jesse Huang, Julia Butt, Anna Lindam, Lucia Alonso-Magdalena, Tomas Bergström, Ingrid Kockum, Tim Waterboer, Tomas Olsson, Henrik Zetterberg, Kaj Blennow, Oluf Andersen, Staffan Nilsson, Peter Sundströ. Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis. Brain : a journal of neurology. 2023-11-06. PMID:37930324. |
to assess the temporal relationship between hhv-6a antibodies and snfl, these ratios were plotted against the time to the clinical onset of multiple sclerosis and compared using locally estimated scatterplot smoothing regressions with 95% confidence intervals (ci). |
2023-11-06 |
2023-11-08 |
human |
| Mehraveh Sadeghi Ivraghi, Mohammad Yasin Zamanian, Reena Gupta, Harun Achmad, Hashem O Alsaab, Ahmed Hjazi, Rosario Mireya Romero-Parra, Enas R Alwaily, Beneen M Hussien, Elham Hakimizade. Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms. CNS neuroscience & therapeutics. 2023-10-31. PMID:37904726. |
experimental studies in vitro and in vivo have shown that gem can prevent or slow the progression of neurological disorders (nds), including cerebral ischemia (ci), alzheimer's disease (ad), parkinson's disease (pd), and multiple sclerosis (ms). |
2023-10-31 |
2023-11-08 |
Not clear |
| Sarah A Morrow, Abedallah A K Balusha, Heather Rosehart, Courtney Casserly, Juan M Racost. Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study. Multiple sclerosis and related disorders. vol 80. 2023-10-22. PMID:37866025. |
cognitive impairment (ci) is common in multiple sclerosis (ms), affecting half of persons with ms (pwms). |
2023-10-22 |
2023-11-08 |
Not clear |
| Bianka Suchá, Pavel Šiarnik, Stanislava Klobucká, Peter Turčáni, Branislav Kollá. Association between cognitive impairment and the disability in people with multiple sclerosis. Neuro endocrinology letters. vol 44. issue 5. 2023-07-31. PMID:37524317. |
cognitive impairment (ci) may be present in people with multiple sclerosis (pwms) in different stages of the disease, as well as in pwms with various degrees of disability. |
2023-07-31 |
2023-08-14 |
Not clear |
| Maria Pia Amato, Roberto Bergamaschi, Diego Centonze, Massimiliano Mirabella, Girolama Alessandra Marfia, Rocco Totaro, Giacomo Lus, Vincenzo Brescia Morra, Umberto Aguglia, Cristoforo Comi, Paola Cavalla, Mauro Zaffaroni, Marco Rovaris, Luigi Maria Grimaldi, Stefania Leoni, Simona Malucchi, Eleonora Baldi, Marcello Romano, Mario Falcini, Paola Perini, Maurizio Assetta, Emilio Portaccio, Sergio Sommacal, Nunzio Olivieri, Franco Parodi, Daniele Santo Todaro, Nicoletta Grassivaro, Alberto Farina, Margaret Mary Mondino, Massimo Filippi, Maria Trojan. Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study. Journal of neurology. 2023-07-05. PMID:37405689. |
cognitive impairment (ci) is a prevalent and debilitating manifestation of multiple sclerosis (ms); however, it is not included in the widely used concept of no evidence of disease activity (neda-3). |
2023-07-05 |
2023-08-14 |
Not clear |
| Frédéric London, Alice De Haan, Zohra Benyahia, Gaëtane Landenne, Thierry Duprez, Vincent van Pesch, Souraya El Sankar. Cognitive trajectories in relapsing-remitting multiple sclerosis: Evidence of multiple evolutionary trends. Multiple sclerosis and related disorders. vol 77. 2023-06-30. PMID:37390678. |
cognitive impairment (ci) frequently occurs in multiple sclerosis (ms) and is assumed to increase over time. |
2023-06-30 |
2023-08-14 |
Not clear |
| Aashrai Sai Venkat Gudlavalleti, John O Elliott, Rafah Asad. Factors Associated With No-Show to Ambulatory Tele-Video Neurology Visits. Cureus. vol 15. issue 5. 2023-06-14. PMID:37313074. |
being married was associated with cvs or = 0.74 (95%, ci: 0.59-0.91) as well as primary diagnoses of multiple sclerosis or = 0.24 (95%, ci: 0.13-0.44) and movement disorders or = 0.41 (95%, ci: 0.25-0.68). |
2023-06-14 |
2023-08-14 |
Not clear |
| Yuki Matsumoto, Kimihiko Kaneko, Toshiyuki Takahashi, Yoshiki Takai, Chihiro Namatame, Hiroshi Kuroda, Tatsuro Misu, Kazuo Fujihara, Masashi Aok. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids. Brain : a journal of neurology. 2023-04-16. PMID:37061817. |
none of aqp4-igg-positive nmosd, multiple sclerosis, or ond cases tested positive for mog-iggserum but two with multiple sclerosis were mog-iggcsf-positive; the specificity of mog-iggserum and mog-iggcsf in suspected mogad were 100% (95%ci 99%-100%) and 99% (97%-100%), respectively. |
2023-04-16 |
2023-08-14 |
Not clear |
| Nataraja Sarma Vaitinadin, C Michael Stein, Jonathan D Mosley, Vivian K Kawa. Genetic susceptibility for autoimmune diseases and white blood cell count. Scientific reports. vol 13. issue 1. 2023-04-11. PMID:37041293. |
the ivwr analyses revealed significant associations between 3 ai diseases and wbc counts: systemic lupus erythematous (beta = - 0.05 [95% ci, - 0.06, - 0.03]), multiple sclerosis (beta = - 0.06 [- 0.10, - 0.03]), and rheumatoid arthritis (beta = 0.02 [0.01, 0.03]). |
2023-04-11 |
2023-08-14 |
Not clear |
| Qian Jiang, Wenjun Wang, Wendong Chen, Yan X. The impact of cognitive impairment on disease burden in Chinese patients with multiple sclerosis: A model simulation study. Multiple sclerosis and related disorders. vol 73. 2023-03-26. PMID:36966649. |
cognitive impairment (ci) is prevalent in chinese patients with relapsing-remitting multiple sclerosis (rrms). |
2023-03-26 |
2023-08-14 |
Not clear |
| Vlad Eugen Tiu, Bogdan Ovidiu Popescu, Iulian Ion Enache, Cristina Tiu, Elena Terecoasa, Cristina Aura Pane. Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis. Diagnostics (Basel, Switzerland). vol 12. issue 11. 2023-03-08. PMID:36359416. |
(1) background: cognitive impairment (ci) begins early in the evolution of multiple sclerosis (ms) but may only become obvious in the later stages of the disease. |
2023-03-08 |
2023-08-16 |
Not clear |